Journal of Hematology & Oncology

official impact factor 2.93

This article is part of the supplement: Current trends in leukemia, lymphoma, myeloma and ITP: updates and highlights from ASH 2008

Open Access Meeting report

What's new in the management of chronic lymphocytic leukemia? 2008 ASH Review (New York Medical College, January 31, 2009)

Kami J Maddocks and Thomas S Lin*

Journal of Hematology & Oncology 2009, 2(Suppl 1):I1 doi:10.1186/1756-8722-2-S1-I1

No comments have yet been made on this article.

Post a comment